Abortive replication of influenza virus in mouse dendritic cells

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5922-5925

  Ioannidis, Lisa J ^a   Verity, Erin E ^b   Crawford, Simon ^a   Rockman, Steven P ^b   Brown, Lorena E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSL LIMITED   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS HEMAGGLUTININ; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; FEMUR; GENE REPLICATION; GENETIC TRANSCRIPTION; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H3N2 PR8; INFLUENZA VIRUS A H3N2 X 31; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS RELEASE; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED C57BL; VIRUS RELEASE; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 84861309083     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07060-11     Document Type: Article

References (26)

1. Albert ML, Sauter B, Bhardwaj N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature 392:86-89.
2. Baez M, Palese P, Kilbourne ED. 1980. Gene composition of highyielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 141:362-365.
3. Bender A, et al. 1998. The distinctive features of influenza virus infection of dendritic cells. Immunobiology 198:552-567.
4. Bender A, Bui LK, Feldman MAV, Larsson M, Bhardwaj N. 1995. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T-cell responses. J. Exp. Med. 182:1663-1671.
5. Bhardwaj N, et al. 1994. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94:797-807.
6. Brown LE, Murray JM, White DO, Jackson DC. 1990. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Arch. Virol. 114:1-26.
7. Cella M, et al. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821-829.
8. Deliyannis G, et al. 2006. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza. Eur. J. Immunol. 36:770-778.
9. Diebold SS, et al. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424:324-328.
10. Hargadon KM, et al. 2011. Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells. J. Virol. 85:11955-11963.
11. Herter S, et al. 2005. Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virusinfected dendritic cells. J. Immunol. 175:891-898.
12. Lau SC, Scholtissek C. 1995. Abortive infection of Vero cells by an influenza A virus (FPV). Virology 212:225-231.
13. López CB, Fernandez-Sesma A, Czelusniak SM, Schulman JL, Moran TM. 2000. A mouse model for immunization with ex vivo virus-infected dendritic cells. Cell. Immunol. 206:107-115.
14. Lutz MB, et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
15. Moltedo B, Li WJ, Yount JS, Moran TM. 2011. Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog. 7(11):e1002345.
16. Mount AM, et al. 2008. Multiple dendritic cell populations activate CD4+ T cells after viral stimulation. PLoS One 3(2):e1691.
17. Nonacs R, Humborg C, Tam JP, Steinman RM. 1992. Mechanisms of mouse spleen dendritic cell function in the generation of influenzaspecific, cytolytic T lymphocytes. J. Exp. Med. 176:519-529.
18. Oh S, McCaffery JM, Eichelberger MC. 2000. Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus. J. Virol. 74:5460-5469.
19. Palese P, Compans RW. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159-163.
20. Palese P, Tobita K, Ueda M, Compans RW. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410.
21. Pei ZF, Harrison MS, Schmitt AP. 2011. Parainfluenza virus 5 m protein interaction with host protein 14-3-3 negatively affects virus particle formation. J. Virol. 85:2050-2059.
22. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4:e1000115.
23. Rodgers B, Mims CA. 1981. Interaction of influenza virus with mouse macrophages. Infect. Immun. 31:751-757.
24. Tate MD, et al. 2011. The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One 6:e17618.
25. Thitithanyanont A, et al. 2007. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J. Immunol. 179:5220-5227.
26. Wells MA, Albrecht P, Daniel S, Ennis FA. 1978. Host defense mechanism against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect. Immun. 22:758-762.